Efficacy and Safety of Ivarmacitinib in Patients With Moderate-to-Severe, Active, Ulcerative Colitis: A Phase II Study
Gastroenterology(2022)
Abstract
Oral ivarmacitinib was found to be a safe and effective therapy for adult patients with moderate-to-severe, active ulcerative colitis, and holds promise as a new treatment option for this condition.
MoreTranslated text
Key words
Ulcerative Colitis,Ivarmacitinib (SHR0302),JAK1 Inhibitor,Safety,Clinical Remission
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined